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Abstract 
 
 
Nanotechnology refers to the production and structural manipulation of materials between 
10-100 nm ranges, known as nanomaterials, which display novel properties. Silver 
nanoparticles (Ag NPs) are said to be the most widely commercialised nanomaterial and it 
has found a wide range of applications in many different fields, including appliances and 
drug delivery systems. Due to their antimicrobial activity, believed to be attributed to the 
release of silver ions, they have been incorporated into many consumer products to serve as 
antibiotic agents. These applications lead to overexposure of organisms and the environment 
to silver which could eventually make its way into the human body via ingestion, inhalation 
and/or dermal contact and we don’t fully comprehend the impact of Ag NPs inside the human 
body.  
Silver nanoparticles were found to accumulate in any or all of the major organs and organ 
systems via circulatory and lymphatic system distribution after introduction to the human 
body via inhalation, ingestion, and/or injection. Various in vitro studies on different cell lines 
have concluded that silver nanoparticles induce oxidative stress, DNA damage, apoptosis, 
and/or necrosis. Diesel exhaust particles showed the ability to decrease sperm motility and 
gold nanoparticles showed a reduction in Leydig cell viability and steroid hormone 
production.  The effect of Ag NP exposure on male fertility is however poorly understood 
and not enough data is available to fully assess risks posed by these particles on male 
reproduction. Therefore, it was the aim of this study to be the first to ascertain the effects of 
silver nanoparticles on testosterone production.  
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The Ag NPs used for this study have the following characteristics; purity ≥ 99.5%; 66.7 % of 
particles have a diameter between 20-40 nm in aqueous solution.  Three month old male 
Balb/C mice were sacrificed and testicular cell cultures were prepared.  The cells were 
subsequently treated with various concentrations of Ag NPs (with or without luteinizing 
hormone (LH)-treatment) and incubated for 4 hours.  Testosterone secretion in the culture 
supernantant was then determined using a testosterone ELISA kit. Ag NPs (at 20 µg/ml) 
significantly (p < 0.001) decreased LH-stimulated testosterone production as compared to the 
control.  This study showed that Ag NPs adversely affect testosterone synthesis in vitro and 
can therefore pose a risk for male reproduction.                        
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Chapter 1: Literature Review 
 
1.1. Nanotechnology: Overview 
 
Nanotechnology refers to the production and structural manipulation of materials between 
10-100 nm ranges, known as nanomaterials, which display novel properties (Braydich-Stolle 
et al., 2005).  Nanomaterials can be grouped into five categories, namely carbon-based 
materials, polymers, metal-based materials, dendrimers, and composites and are found in 
different shapes, such as, rods, tubes, wires, different crystal forms, spheres or core-shell 
nanoparticles (NPs) (Lü et al., 2009; Kruszewski et al., 2011).  The large surface-to-volume 
ratio in conjunction with other physiochemical properties, such as composition, surface 
chemistry and quantum confinement effects, make researchers believe that these 
nanomaterials may be harmful to the environment and biological organisms that live in it 
(Kruszewski et al., 2011).  Despite this, many nanomaterials are continuously being 
manufactured for use in various industries.  
1.2 Applications of silver nanoparticles  
 
Silver nanoparticles (Ag NPs) are said to be the most widely commercialised nanomaterial 
and it has found a wide range of applications in many different fields (Braydich-Stolle et al., 
2010).  Xiu et al. (2012) states that the release of silver ions (Ag+) are exclusively 
responsible for the antimicrobial activity of Ag NPs.  Due to their antimicrobial activity they 
have been incorporated into many consumer products to serve as antibiotic agents, including 
appliances such as washing machines and refrigerators, textiles, wound healing and medical 
products such as surgical instruments, contraceptive devices, bone prostheses as well as 
dental alloys (Stensberg et al., 2011; Tian et al., 2007; Kruszewski et al., 2011).  Ag NPs 
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have also been used to treat diseases such as HIV subtype 1, where it was shown, in vitro, 
that Ag NPs, in the size range of 1-10 nm, bind to the HIV subtype 1 virus and thus prevent it 
from binding to the host cells (Elechiguerra et al., 2005).  These applications, as drug 
delivery systems and treatments of diseases, require the need for a constant concentration of 
the drug (in these cases Ag NPs) in the blood for targeting of specific cells or organs 
(Moghimi et al., 2001; Panyam & Labhasetwar, 2003).  This leads to overexposure of 
organisms and the environment to silver which could eventually make its way into the human 
body via ingestion, inhalation and/or dermal contact and we don’t fully comprehend the 
impact of Ag NPs inside the human body (Kulthong et al., 2010).  Benn & Westerhoff (2008) 
showed that Ag NPs that are incorporated into fabrics such as socks do leach out silver upon 
washing of the items.  It was found that Ag NPs incorporated into antibacterial fabrics, such 
as wound dressings, are released upon interaction with artificial sweat and since Ag NPs are 
able to penetrate through the skin,  it becomes paramount that the toxicological effects of Ag 
NPs be better understood (Kulthong et al., 2010; Larese et al., 2009).  AshaRani et al. (2011) 
also discovered that Ag NPs causes haemolysis at concentrations of between 25-400 mg/ml, 
leading to further concerns with regards to wound dressings and other products that will come 
into contact with the skin.   
1.3 Uptake of Ag NPs 
 
Ag NP’s cellular uptake is said to be fast and time-dependent.  In as little as 2 hours almost 
all cells contain Ag NPs (Kruszewski et al., 2011).  Gaiser et al. (2009) found that Ag NPs 
sized 35 nm were more readily found and taken up into the cytoplasm of C3A human 
hepatocytes or Caco-2 human intestinal epithelial cells than bulk silver particles (0.6-1.6 µm) 
after 2 hours and 24 hours of exposure.  Lu et al. (2010) demonstrated, via transmission 
electron microscopy (TEM), that all forms of silver nanomaterials (colloidal and powder 
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spheres, colloidal and powder prisms) are assimilated in more or less the same manner.  The 
uptake of both the 30 nm silver nanospheres and the 30 nm silver nanoprisms, into human 
HaCaT keratinocytes, accumulated in the nucleus in 7 hours.   However, the surface charge of 
Ag NPs was shown to be a significant factor in its uptake into the cellular environment 
(Lesniak et al., 2005; Gregas et al., 2010).  Previous studies found that positively or 
negatively charged Ag NPs (50 nm) were more readily taken up than their neutral 
counterparts (Lesniak et al., 2005; Gregas et al., 2010).   
 
Studies have found that human mesenchymal stem cells internalised Ag NPs via 
macropinocytosis and clathrin-dependent endocytosis and this internalisation is influenced by 
different factors, including morphology and surface chemistry, as well as size and 
concentration (Greulich et al., 2010; Mailander & Landfester, 2009).  Yen et al. (2009), 
however, found evidence that showed that coated and uncoated Ag NPs were taken up into 
J774 A1 macrophages via pinocytosis.  Whichever mechanism is used for internalisation of 
Ag NPs, studies have shown that internalisation of these Ag NPs result in the production of 
reactive oxygen species (ROS), inflammation and ultimately cell death (Ahamed et al., 2008; 
Ahamed et al., 2010; AshaRani et al., 2009b).  Bhakat et al. (2006) and Paz-Elizur et al. 
(2008) states that ROS has DNA damaging effects, such as causing a whole host of oxidised 
base lesions, both single-strand and double-strand breaks and abasic sites, which are 
ultimately mutagenic and/or cytotoxic.  Both Hussain & Frazier (2003) and Li & Osborne 
(2008) stated that ROS synthesis in excessive amounts induce apoptosis in a number of cell 
culture models.  
Asare et al. (2012) postulated that since Ag NPs are able to interact with nuclear material it 
can lead to DNA alterations, and if applied to the germline cells, it might affect 
spermatogenesis and fertility (AshaRani et al., 2009a; Kruszewski et al., 2011).  This will 
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have devastating effects on the reproductive rate and population dynamics of the species 
affected. 
VanWinkle et al. (2009) found that only smaller Ag NPs (< 20 nm) cross the cell membrane 
of rat type I-like alveolar epithelial cells and were uniformly distributed without 
agglomeration within the cytosol, mitochondria, and cell nucleus.  
The toxicity of Ag NPs seems to be dictated by shape, size, surface chemistry and surface 
charge as these factors directly impacts on the extent, rate, location and/or timing of Ag+ 
release (Pal et al., 2007; Morones et al., 2005; Sotiriou & Pratsinis 2010; Ahamed et al., 
2008;  Lesniak et al., 2005; Gregas et al., 2010; Xiu et al., 2012). 
1.4 Environmental impact of Ag NPs  
 
Ag NP containing products leach the Ag NPs into the environment which may lead to 
bioaccumulation, food chain contamination and/or drinking water contamination (Karn et al., 
2009; Gao et al., 2009).  Kruszewski et al. (2011) states that the toxicological outcome of 
these Ag NPs lies in the nature of the NPs.  The NPs will either end up in the soil if it is able 
to interact with natural materials or it can remain in the water where it can be exposed to 
various organisms.  It thus becomes very relevant to understand the toxicity of Ag NPs on the 
organisms and the environment since they will most likely enter into the human food chain 
by some way or another.  Several toxicological studies have been done on fish species. 
AshaRani et al. (2008) exposed zebrafish (Danio rerio) embryos to either 5-20 nm BSA – or 
starch coated Ag NPs at a concentration of 5-100 µg/ml for 24, 48 & 72 hours post-
fertilisation.  The study revealed that the toxicity was dose-dependent and that it caused 
several embryonic malformations (AshaRani et al., 2008).  Lee et al. (2007) also looked at 
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the Ag NP toxicity in Zebrafish embryos.  They administered uncoated 5-46 nm Ag NPs at 
concentrations of 0.004-0.08 µg/ml for 24-120 hours and their results were similar to the 
results obtained by AshaRani et al. (2008).  
Adult zebrafish assimilate Ag NPs through the gills which caused alterations in gene 
expression and increased the death rate (Griffitt et al., 2008; Griffitt et al., 2009).  Wu et al. 
(2010) also discovered increased mortality in adult Japanese medaka (Oryzias latipes) 
exposed to 20-40 nm uncoated Ag NPs at concentrations between 0.5-8 µg/ml.  Ag NPs are 
said to partially degrade in vivo, leading to release of Ag
+
, but studies suggest that there are 
noticeable differences between the toxicity caused by Ag
+
 as opposed to Ag NPs (Bar-Ilan et 
al., 2009; Chae et al., 2009; Gaiser et al., 2009).  Kruszewski et al. (2011) proposes that this 
strengthens the argument that the release of Ag
+
 is not the only factor in Ag NPs toxicity.  
  
 
 
 
 
 6 
 
Table 1: A non-exhaustive summary of the environmental impact of Ag NPs 
 
Test species Size (nm) of 
NP 
Surface 
coating of NP 
Concentration of NP 
tested 
Exposure duration Outcome References 
Japanese medaka 
(O. latipes) at 
early-life stages 
20-40 None  0.5-8 µg/ml fish 
0.5-4 µg/ml 
eggs 
0.1-1 µg/ml 
Embryos 
48 h 
 
168 h 
 
60 days 
Developmental retardation 
and morphological 
defects in embryonic 
larvae, toxicity in 
larval-juvenile medaka, 
histopathological 
changes in the larval eye 
Wu et al., 
2010 
Zebrafish (D. rerio) 
Embryos 
26, 44 and 
216 in 
Medium 
None 1 µg/ml 48 h Toxicity, changes in 
gills morphology and 
gene expression 
Griffitt et al., 
2009; 2008 
Zebrafish (D. rerio) 
Embryos 
6-20 BSA and 
starch 
Coated 
5-100 µg/ml 24, 48, 72 h 
postfertilization 
Dose-dependent 
cytotoxicity, genotoxicity 
& metabolic arrest  
AshaRani et 
al., 2008 
Zebrafish (D. rerio) 
Embryos 
5-46 None 0.004-0.08 µg/ml 24-120 h Dose-dependent mortality 
and developmental 
abnormality in embryos 
Lee et al., 
2007 
 
 
 
 
 
 
 
 
 7 
 
1.5 Studies on Ag NPs 
 
 
1.5.1 In vitro studies using Ag NPs  
 
The parameters which influence Ag NP toxicity include size, type, zeta potential, 
agglomeration and/or dispersion status as well as potential interaction with biomolecules 
(Asare et al., 2012).  AshaRani et al. (2009b) used IMR-90 human lung fibroblast and U251 
human glioblastoma cells and exposed them to 6-20 nm starch coated Ag NPs at 
concentrations of 25-400 µg/ml for 24, 48 and 72 hours.  Their results indicated oxidative 
stress, DNA damage, apoptosis, necrosis and low ATP levels all suggesting metabolic arrest 
(AshaRani et al., 2009b).  Schrand et al. (2008) exposed N2A murine neuroblastoma cells to 
25 nm uncoated and polysaccharide coated Ag NPs at a concentration of 0.5-100 µg/ml for 
24 hours.  They found that this resulted in disruption of the actin cytoskeleton, oxidative 
stress degradation of mitochondrial integrity and decreased cell proliferation that continued 
even after the administration of nerve growth factor (Schrand et al., 2008).  The 
administration of 3.08, 5.75 and 24.85 nm uncoated Ag NPs to J774 A1 macrophages at 
concentrations of 1-10 µg/ml for 24, 48 and 72 hours resulted in cytotoxicity only being seen 
in the cells exposed to the smaller Ag NPs (Yen et al., 2009) .  This may suggest that only the 
smaller Ag NPs are able to enter the cells causing damage. 
Greulich et al. (2009) administered 100 nm spherical Polyvinylpyrrolidone-coated Ag NPs to 
human mesenchymal stem cells (hMSCs) at a concentration of 0.05-50 µg/ml for 7 days.  The 
results of which showed decreased cell proliferation and chemotaxis as well as increased 
release of IL-8.  AshaRani et al. (2011) showed a concentration dependent toxic effect of 
both polyvinyl acetate- and starch-coated Ag NPs on human erythrocytes and 
haemagglutination resulting in swelling of cells, haemolysis and a loss in biconcavity.  
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Reduced cell viability, DNA fragmentation and oxidative stress was evident when HT-1080 
human fibrosarcoma cells derived from dermis, and A431 human skin carcinoma cells 
derived from the epidermis were treated with  7-20 nm uncoated Ag NPs at concentrations of 
1.56-50 µg/ml for 24 hours (Arora et al., 2008).  Kokura et al. (2010) observed no increase in 
cell death when they exposed human skin and HaCaT normal human keratinocytes to 730.5 
nm cellulose gum coated Ag NPs at concentrations of 0.5-50 µg/ml (skin) and 0.002-0.02 
µg/ml (keratinocytes) for 24 hours.  It should be noted that the NPs used were quite large and 
at concentrations lower than that used in other studies.  This again suggests that toxicity only 
occurs above a certain concentration and that since larger NPs are unable to enter the cell no 
toxicological effect is shown by them. 
An interesting study by Kawata et al. (2009) found that 90 nm polyethylamine-stabilized Ag 
NPs were beneficial (increased cellular proliferation) to HepG2 human hepatocytes at 
concentrations under 1 µg/ml, but at concentrations greater than 1 µg/ml the effects became 
toxic.  The opposite was discovered by Rosas-Hernández et al. (2009) who found that rat 
coronary endothelial cells exposed to low concentrations (1-10 µg/ml) of 45 nm uncoated Ag 
NPs showed inhibited proliferation, but at higher concentrations (50-100 µg/ml) the Ag NPs 
resulted in increased proliferation.  Li et al. (2010) studied the effects of Ag NPs on 
embryonic development using mouse blastocysts as a model.  Mouse blastocysts exposed to 
13 nm uncoated Ag NPs at concentrations of 25 and 50 µM for 24 hours showed inhibition of 
cell proliferation and induction of apoptosis (Li et al., 2010).  This may suggest that Ag NPs 
are detrimental to reproduction as it affects embryonic implantation and development. 
The importance of surface chemistry on toxicity was shown when Ahamed et al. (2008) 
exposed mouse embryonic stem cells and mouse embryonic fibroblasts to 25 nm uncoated 
and polysaccharide (acacia gum)-coated Ag NPs and found that the coated Ag NPs exerted a 
greater effect on DNA damage and apoptosis than the uncoated Ag NPs.  Murdock et al. 
 
 
 
 
 9 
 
(2007) states that agglomeration tends to develop with the uncoated NPs while the coated 
NPs remain monodispersed.  Ahamed et al. (2008) postulates that this could be the reason for 
the increased toxic effect of coated NPs, as the agglomerated uncoated NPs would most 
likely be too large to be internalised into the cells while the coated NPs are small enough to 
enter into and be distributed throughout the cell.  Furthermore, Ahamed et al. (2008) found 
that there was an almost immediate increase in the expression of p53 protein upon exposure 
to the Ag NPs.  Since p53 activation is closely linked to DNA damage, this then shows 
potential Ag NPs genotoxicity (Liu & Kulesz-Martin, 2001). 
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Table 2: A non-exhaustive summary of in vitro studies using Ag NPs 
Test species Size (nm) 
of NP 
Surface coating 
of NP 
Concentration of 
NP 
Tested 
Exposure 
duration 
Outcome References 
Human erythrocytes 10.88 
(PVA) 
5.78 
(starch) 
PVA coated, 
starch coated 
25-400 µg/ml 3h haemagglutination resulting in 
swelling of cells, haemolysis and 
a loss in biconcavity 
AshaRani et 
al., 2011 
Human skin, HaCaT 
normal human 
keratinocytes 
730.5 Cellulose gum-
coated 
0.5, 50 µg/ml (skin), 
0.002-0.02 µg/ml 
(keratinocytes) 
24h No increase in cell death Kokura et al., 
2010 
Mouse blastocysts 13 None  25 and 50 µM 24h Inhibition of cell proliferation 
and induction of apoptosis  
Li et al., 2010 
IMR-90 human 
lung fibroblast, 
U251 human 
glioblastoma cells 
6-20 Starch coated 0, 100, 200 and 400 
μg/ml 
2-3 hours Chromosome instability and 
mitotic arrest in human cells. 
Upregulation of stress response 
genes. Calcium transients 
AshaRani et 
al., 2009a 
IMR-90 human 
lung fibroblast, 
U251 human 
glioblastoma cells 
6-20 Starch 
Coated 
25-400 µg/ml 24, 48, 72 h 
 
Cytotoxicity, production 
of IL1, IL6, and TNF 
AshaRani et 
al., 2009b 
HepG2 human 
hepatoma cells 
90 Polyethylenimine 
Stabilized 
1-3 µg/ml 24h Increased cell proliferation < 0.5 
µg/ml cytotoxic > 1 µg/ml 
Kawata et al., 
2009 
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Table 2 continued 
Test species Size 
(nm) of 
NP 
Surface 
coating of NP 
Concentration of 
NP 
tested 
Exposure 
duration 
Outcome References 
Rat coronary 
endothelial cells 
45 None  0.1-100 µg/ml 24 h Inhibited proliferation (1–10 
µg/ml), increased proliferation (50–
100 µg/ml)  
Rosas-Hernández 
et al., 2009 
J774 A1 
macrophages 
3.08, 
5.75, 
and 
24.85 
None 1-10 µg/ml 24, 48, 72 h 
 
Cytotoxicity, production 
of IL1, IL6, and TNF 
Yen et al., 2009 
Mouse embryonic 
stem cells (mES), 
mouse embryonic 
fibroblasts (mEF) 
25 Uncoated, 
polysaccharide 
coated 
50 µg/ml 24, 48, 72 h 
 
Coated NPs exerted greater DNA 
damage and apoptosis inducing 
effects than uncoated NPs 
Ahamed at al., 
2008 
HT-1080 human 
fibrosarcoma cells 
derived from 
dermis,  
A431 human skin 
carcinoma cells 
derived from 
epidermis 
7-20 None  1.56-50 µg/ml 24h Reduced cell viability, DNA 
fragmentation and oxidative stress 
Arora et al., 2008 
N2A murine 
neuroblastoma cells 
25 Uncoated, 
polysaccharide 
coated 
0.5-100 µg/ml 24h Oxidative stress, degradation of 
mitochondrial membrane integrity, 
disruption of actin 
Cytoskeleton 
Schrand et al., 
2008 
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Table 2 continued 
Test species Size (nm) of NP Surface coating 
of NP 
Concentration of 
NP 
tested 
Exposure 
duration 
Outcome References 
Human 
mesenchymal 
stem cells 
(hMSCs) 
100  PVP coated 0.05-50 µg/ml  
 
7 days Cell proliferation 
and chemotaxis 
were decreased, 
IL8 release was 
increased 
Wu et al., 2008 
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1.5.2 In vivo studies using Ag NPs 
 
In vivo studies regarding Ag NPs are only limited to non-human organisms and limited in 
number (Kruszewski et al., 2011).  McAuliffe et al. (2007) states that after the introduction of 
NPs into the human body via inhalation, ingestion, and/or injection, they can accumulate in 
any or all of the major organs and organ systems via circulatory and lymphatic system 
distribution (Panyala et al., 2008).  Ag NPs cannot only traverse blood vessels, but they can 
also cross the biological barriers of the body, such as the blood-brain barrier and the blood-
testes barrier (Lankveld et al., 2010; McAuliffe et al., 2007).  Acute and chronic exposure to 
Ag NPs affects several physiological functions (Sung et al., 2011; Lankveld et al., 2010).  
Lee et al. (2010) exposed C57BL/6 mice to Ag NPs and found that several genes linked with 
motor neuron disorders, neurodegenerative disease, and immune cell function in brain had 
been affected.  Takenaka et al. (2001) compared the differences between 10nm and 100nm 
Ag NPs administered via inhalation and intratracheal exposure, resulting in the accumulation 
of Ag NPs in the blood and the lungs.  Ji et al. (2007) showed a dose-related accumulation in 
lungs, brain, olfactory bulb and liver.  Sprague-Dawley rats exposed via inhalation to Ag NPs 
exhibited no lesions discovered in the nasal cavity or lungs upon histopathological 
examination; however, there was a marked increase in growth of goblet cells, as well as an 
increase in neutral mucous production after the administration of high doses (Ji et al., 2007; 
Hyun et al., 2008).  Sung et al. (2008) administered 18 nm Ag NPs 6 hours a day, 5 days per 
week for 90 days via inhalation to Sprague-Dawley rats and found that there was a decrease 
in the rats’ tidal volume as well as an increase in bile duct hyperplasia and liver 
inflammation.  Another study investigated the subchronic inhalation administration of 18-19 
nm Ag NPs (6 hours per day, 5 days per week for 13 weeks) on Sprague-Dawley rats and 
found that the highest dose (3.0 X 10
6
 particle/cm
3
) resulted in macrophage accumulation in 
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the lungs, alveolar inflammation as well as increased bile duct hyperplasia (Sung et al., 
2009).  
The oral exposure of male and female Fischer F344 rats to 56 nm Ag NPs resulted in dose-
dependent increases in cholesterol and alkaline phosphatase levels in blood, bile-duct 
hyperplasia, necrosis, fibrosis, and/or pigmentation changes in liver tissue (Kim et al., 2010).  
Histological changes in the intestinal mucosa as well as changes in the secretion of mucin 
was evident after the 28 day oral exposure (30, 300, 1000 mg/kg) of Sprague-Dawley rats to 
60 nm Ag NPs (Jeong et al., 2010).  Both Tang et al. (2008) and Tang et al. (2009) studied 
the difference between Ag NPs versus Ag microparticles in their ability to cross the blood-
brain barrier and the ability to cross into the cardiovascular system after subcutaneous 
exposure, respectively.  It was found that only the Ag NPs are able to cross the blood-brain 
barrier as well as cross over into the cardiovascular system upon subcutaneous 
administration, the latter ending with accumulation in various organs, including spleen, 
kidneys, brain, liver and lungs.  Ag NPs showed a size-dependent accumulation pattern, 
where large particles (100 nm) were located in the spleen (~4000 ng/g organ), liver (~2000 
ng/g organ), and lungs (~1000 ng/g organ) and smaller particles (20 nm) were found in the 
liver (~1000 ng/g organ), kidneys (~300 ng/g organ), and spleen (~200 ng/g organ) (Lankveld 
et al., 2010).  Rahman et al. (2009) intraparentally exposed C57BL/6N mice to 29 nm Ag 
NPs (100, 500, and 1000 mg/kg) for 24 hours and this resulted in oxidative stress-related 
altered gene expression in the caudate, frontal cortex, and hippocampus regions of the brain. 
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Table 3: A non-exhaustive summary of in vivo studies using Ag NPs 
Test species Size (nm) 
of NP 
Surface 
coating of 
NP 
Concentration of NP 
Tested 
Exposure duration Outcome References 
Sprague-Dawley 
Rats 
60  None  30, 300, 1000 mg/kg Ingestion  28 days Histological changes in the 
intestinal mucosa as well as 
changes in the secretion of mucin 
Jeong et al., 
2010 
Fischer 
F344 rats 
56 None  30, 125, and 500 
mg/kg 
body weight 
Ingestion  90 days dose-dependent effects, such as an 
increase in cholesterol and alkaline 
phosphatase levels in blood, bile-
duct hyperplasia, necrosis, fibrosis, 
and/or pigmentation changes in 
liver tissue 
 
Kim et al., 
2010 
Rats 20, 80, 110 None  23.8, 26.4, 27.6 µg/ml Intravenously Size-dependent deposition in all 
major organs 
Lankveld et 
al., 2010 
 
C57BL/6 
Mice 
22 None  1.91 x 10
7 
particles/ 
cm3 
Inhalation exposure: 
6 h/day, 5 days/ 
week, 14 days 
affects several genes linked with 
motor neuron disorders, 
neurodegenerative disease, and 
immune cell function in brain 
Lee et al., 
2010 
C57BL/6N 
Mice 
29  None  100, 500, and 
1000 mg/kg 
Intraparentally 24 h Oxidative stress-related altered 
gene expression in the caudate, 
frontal cortex, and hippocampus 
regions of the brain. 
Rahman et al., 
2009 
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Table 3 continued  
Test 
species 
Size 
(nm) of 
NP 
Surface 
coating 
of NP 
Concentration of 
NP 
Tested 
Exposure duration Outcome References 
Sprague- 
Dawley 
Rats 
18-19 None  0,6 x 10
6
, 1.4 x 10
6
, 
3.0 x 10
6
 particles/ 
cm
3
 
Inhalation exposure: 
6 h/day, 5 days/ 
week, for 13 
weeks 
Macrophage accumulation in the lungs, 
alveolar inflammation as well as increased 
bile duct hyperplasia 
Sung et al., 2009 
Rats 50-100,  
2-20 
µm 
None 62.8 mg/kg Subcutaneously AgNPs translocated to the blood 
circulation system and distributed 
throughout the main organs. Caused 
neuronal degeneration 
Tang et al., 2009 
Sprague- 
Dawley 
Rats 
13-15 None  1.73 x 10
4
, 
1.27 x 10
5
, 
1.32 x 10
6
 
particles/ cm
3
µg/ml  
(61 µg /m
3
) 
Inhalation exposure: 
6 h/day, 5 days/ 
week, for 28 days 
Size and number of goblet cells 
containing neutral mucins 
increased in lungs 
Hyun et al., 2008 
Sprague- 
Dawley 
Rats 
18 None  1.73 x 10
4
, 
1.27 x 10
5
, 
1.32 x 10
6
 
particles/ cm
3
 
Inhalation exposure: 
6 h/day, 5 days/ 
week, for 90 days 
Decrease in the rats’ tidal volume chronic 
alveolar inflammation, including 
alveolaritis, granulomatous lesions, and 
alveolar wall thickening.  
Sung et al., 2008 
 
 
 
 
Rats 50-100,  
2-20 
µm 
None 62.8 mg/kg Subcutaneously AgNPs traversed the blood–brain barrier 
(BBB) and move into the brain in the form 
of particles. Induction of 
neuronal degeneration and 
necrosis 
Tang et al., 2008 
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Table 3 continued 
Test species Size (nm) 
of NP 
Surface coating of 
NP 
Concentration 
of NP 
Tested 
Exposure duration Outcome References 
Sprague- 
Dawley 
Rats 
18 None 1.73 x 10
4
 
1.27 x 10
5
 
1.32 x 10
6
 
particles/ cm
3
 
Inhalation exposure: 
6 h/day, 5 days/ 
week, for 28 days 
Dose-related accumulation in 
lungs, brain, olfactory bulb 
and liver. 
Ji et al., 2007 
Fischer 
F344 rats 
15 None  Inhalation 
133 µg/m
3
 
(3 x 10
6 
 cm
3
) 
Intratracheal 
50 µg AgNPs  
24h Dose dependent translocation 
to major organs  
Takenaka et al., 
2001 
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1.5.3 Studies of Ag NPs on male reproductive cells  
 
Although a major cause for concern, there are not many studies done to assess the impact of 
silver nanoparticles on the male reproductive system.  Asare et al. (2012) assessed the 
differences in cytotoxic and genotoxic effects of Ag NPs and titanium oxide nanoparticles 
(TiO2-NPs) on testicular cells by using 8-12 week old 8-oxoguanine DNA glycosylase 
knockout male mice (Ogg1−/− KO) and Ntera2 (NT2, human testicular embryonic carcinoma 
cell line) cells.  Ag NPs (20 nm & 200 nm) and TiO2-NPs (21 nm) were fed to the Ogg1−/− 
KO mice together with their standard chow.  The testicular cells were exposed to 
concentrations of 10, 50 and 100 µg/ml for 24, 48 and 72 hours.  The Ogg1−/− KO genotype 
were used because they possess an impaired oxidative DNA damage repair system similar to 
human testicular cells and thereby they represent an appropriate model for human male 
reproductive toxicity assays.  The study found that the Ag NPs had a more potent cytotoxic 
and cytostatic effect compared to the TiO2-NPs (Asare et al., 2012).  The Ag NPs caused 
several effects in a time- and concentration dependent manner, including apoptosis, necrosis 
and as well as a decrease in proliferation.  Asare et al. (2012) found a concentration 
dependent increase in DNA strand breaks with regards to the larger Ag NPs (200 nm).  This 
DNA strand damaging effect may lead to alterations and mutations in the DNA, which could 
be passed onto offspring via genetic and epigenetic mechanisms, thus impacting on the future 
population of the affected species.  The study also found that at the highest concentration 
(100 µg/ml) the metabolic activity of all three cell types were already reduced by an 
estimated 50% compared to the controls.  In a study by Gromadzka-Ostrowska et al. (2012) 
they used 20 nm and 200 nm spherical Ag NPs on 96 adult 14 weeks old male Wistar rats 
(strain: Wistar Cmd: WI(WU)) that were divided into 4 groups who received either one single 
dose of 5 mg/kg or 10 mg/kg of 20 nm Ag NPs or 5 mg/kg of the 200 nm Ag NPs and a 
control group injected with 0.9% NaCl solution.  They determined the acute effects of the 
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intravenous administration of Ag NPs on several parameters, including sperm count, 
abnormal spermatozoa frequency, germ cell DNA damage in sperm cells and testis 
morphometry.  They found that the 20 nm Ag NPs caused germ cell DNA damage that 
peaked at 24 hours post injection, after which it decreased gradually for some time (7 and 28 
days later).  They postulated that the decreased effects were due to the removal of Ag NPs 
from the organism and DNA damage repair.  They also noted that the highest DNA damage 
was found amongst the group that received the 20 nm Ag NPs treatments.  It was postulated 
that the NP size effects could be due to the fact that smaller NPs are able to enter the cell 
more readily than the larger NPs.  Liu et al. (2010) stated that the smaller NPs have a larger 
surface area, which is able to interact more with the environment and also increase the ion 
release.  Although there were no differences in weight between the different subject groups, 
they found marked differences in the morphology of the testicles.  These differences included 
seminiferous tubules with increased diameter, area and circumference in the animals exposed 
to 200 nm Ag NPs 28 days post injection.  The evidence, they suggested, pointed to the 
theory that bioaccumulation of the 200 nm Ag NPs caused the seminiferous tubules to swell 
up.  The authors argue that since Lankveld et al. (2010) stated that only 1% of the injected 
dose of Ag NPs accumulates in the testes no matter what the size, the amount of Ag NPs 
needed to bring about a negative effect on male fertility is very low.  They also found that the 
treatment with Ag NPs resulted in decreased levels of testosterone as well as 
dihydrotestosterone measured at day 7 and day 28 post injection.  In all the treated groups the 
number of abnormal spermatozoa (folded, amorphous spermatozoa, cells lacking or showing 
a small hook and cells with undulating or elongated heads) 28 days after injection, which is 
the time it takes for two cycles of germ cells to pass through the epididymis, was higher when 
compared with the number 24 hours post injection.  This indicates a greater impact of Ag 
NPs on epididymis than the testes.  They concluded that the toxicity of Ag NPs is more 
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apparent in the mature sperm cells in the epididymis than in the spermatozoa located in the 
seminiferous epithelium.  
Braydich-Stolle et al. (2005) found that the effects described in other cell types were also true 
for mouse spermatogonia stem cells.  They ascertained that Ag NPs exposure resulted in 
apopotosis, necrosis and mitochondrial dysfunction.  Nanoparticles also showed the ability to 
decrease sperm motility and Gold NPs showed a reduction in Leydig cell viability and steroid 
hormone production (Wiwantitkit et al., 2009; Komatsu et al., 2008). 
Takeda et al. (2009) showed that TiO2-NP’s in vivo effects on spermatogenesis by decreasing 
epididymal sperm motility and inducing histopathological changes in mice testes.  TiO2-NPs 
also caused a marked decrease in sperm density and motility as well as increased sperm 
abnormality and germ cell apoptosis (Guo et al., 2009).  Ag NPs induced apoptosis in mouse 
embryos at the blastocyst stage, reduced implantation frequency as well as delayed post-
implantation embryo development (Li et al., 2010).  Ag NPs administration also decreases 
foetus viability (Philbrook et al., 2011).  The effect of Ag NP exposure on male fertility is 
however poorly understood and not enough data is available to fully assess risks posed by 
these particles on male reproduction.  
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Table 4: A non-exhaustive summary of Studies of Ag NPs on male reproductive cells 
Test species Size (nm) of NP Surface 
coating of 
NP 
Concentration 
of NP 
Tested 
Exposure 
duration 
Outcome References 
8-12 week old male 
(Ogg1−/− KO) and 
Ntera2 cells 
Ag NPs (20 nm & 
200 nm) & TiO2-
NPs (21 nm)  
 
 
 
None  10, 50 and 100 
µg/ml 
Mice were fed 
the Ag NPs  
with their feed 
 
Cells exposed 
for 24, 48 and 
72 hours 
Ag NPs were more toxic than 
TiO2-NPs.  Ag NPs caused 
several effects in a time- and 
concentration dependent 
manner, including apoptosis, 
necrosis and as well as a 
decrease in proliferation 
Asare et al., 2012 
96 adult 14 weeks 
old male Wistar rats 
(strain: Wistar Cmd: 
WI(WU)) 
20 and 200 None  One single dose 
of 5 mg/kg or 10 
mg/kg of 20 nm 
Ag NPs or 5 
mg/kg of the 
200 nm Ag NPs 
and a control 
group injected 
with 0.9% NaCl 
solution 
Intravenously The 20 nm Ag NPs caused 
germ cell DNA damage that 
peaked at 24 hours post 
injection, after which it 
decreased gradually for some 
time (7 and 28 days later) 
Seminiferous tubules with 
increased diameter, area and 
circumference were evident in 
the animals exposed to 200 nm 
Ag NPs 28 days post injection. 
 
 
 
Gromadzka-
Ostrowska et al., 
2012 
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Table 4 continued 
 
Test species Size (nm) Surface coating Concentration 
Tested 
Exposure 
duration 
Outcome References 
C18–4 cell line 
established from 
type A 
spermatogonia 
isolated from 6-
day-old mouse 
testes 
Silver (Ag-15 
nm), molybdenum 
(MoO3-30 nm), 
and aluminum 
(Al-30 nm) 
 
Cadmium oxide 
(positive control 
None 5, 10, 25, 50, and 
100 µg/ml 
 
 
 
 
1, 2, 5, 10, and 25  
µg/ml 
48 hours Ag NPs exposure 
resulted in 
apopotosis, 
necrosis and 
mitochondrial 
dysfunction 
Braydich-Stolle et 
al., 2005 
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Chapter 2 
2.1 Problem Statement 
 
The toxicity studies done on Ag NPs have shown varying degrees of toxicological activity in 
different species, organs, as well as cell lines.  Some studies suggest that Ag NPs possess a 
cytotoxic and pro-inflammatory effect resulting from the increased production of ROS, 
cytokine release and upregulation of heat shock proteins (Kruszewski et al., 2011; Daniel et 
al., 2010; Sung et al., 2009).  Other studies point towards apoptosis and necrosis being an 
effect of Ag NP toxicity and that it also causes DNA damage and cell cycle progression 
disturbance (Asare et al., 2012; Lankoff et al., 2011; Wijnhoven et al., 2009).  Bouwmeester 
et al. (2011), suggests that Ag NPs causes changes in the gene expression profile of cells, in 
particular the oxidative stress related genes.  All the studies scrutinised point out that Ag NPs 
are toxic to the cells assessed in a time- and concentration dependent manner.  
Consumer products, such as antibacterial socks and medical applications, such as potential 
anti-HIV agents, using Ag NPs have increased at an alarming rate, despite the lack of 
toxicological data on the effects of these Ag NPs on the human body.  This is especially true 
concerning the effect of Ag NPs on the male reproductive system.  Previous studies 
summarised in the literature review (Chapter 1) have pointed towards some degree of toxicity 
by Ag NPs on the male reproductive tract and suggest that Ag NPs could affect the offspring 
of the affected species and subsequent generations (Asare et al., 2012).  Since we have 
already established the environmental impact of Ag NPs and that several species has been 
shown to internalise the Ag NPs directly from their environment, it can be postulated that not 
only can food supply dwindle, but humans can also get exposed to these Ag NPs by 
consuming the fauna that have internalised it (Griffitt et al., 2008; 2009). 
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A more pressing matter would be the effect these Ag NPs have on the quality of sperm and 
consequently, reproductive ability.  Carlsen et al. (1992) states that semen quality has 
significantly decreased during a 50 year span, measured by a decrease in sperm count from 
113x 10
6
/ml in 1940 to 66x 10
6
/ml in 1990 and a reduction in mean seminal volume from 
3.40 ml to 2.75 ml in the same period among men with no history of infertility.  Auger et al. 
(1995) found no decrease in seminal volume, but found a reduction in mean sperm 
concentration as well as a decrease in the percentages of normal and motile spermatozoa from 
1973 to 1992.  Both these articles show a remarkable decline in the quality of sperm even 
before the advent of nanoparticles in our everyday lives.  It would be interesting to see 
whether Ag NPs will add on to the decline in sperm quality.  
It is thus the aim of this study to determine whether Ag NPs affects spermatogenesis by 
assessing its influence on testosterone production. 
 
2.2 Hypothesis 
 
H0: Ag NPs has no effect on testosterone production by testicular cells. 
H1: Ag NPs affects testosterone production by testicular cells. 
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Chapter 3: The effect of Silver Nanoparticles (Ag NPs) on testosterone 
production using primary testicular cell cultures (minced testes assay) 
 
3.1 Abstract 
 
This study aimed to ascertain the effects of Ag NPs on the male reproductive system in vitro 
by utilising mouse testicular cell cultures.  Ag NPs are the most widely commercialised 
nanomaterial with a wide range of applications in many different fields.  The Ag NPs used 
for this study have the following characteristics; purity ≥ 99.5%; 66.7 % of particles have a 
diameter between 20-40 nm in aqueous solution.  Three month old male Balb/C mice were 
sacrificed and testicular cell cultures were prepared.  Cells were subsequently treated with 
various concentrations of Ag NPs (with or without luteinizing hormone (LH)-treatment) and 
incubated for 4 hours.  Testosterone secretion in the culture supernantant was then 
determined using a testosterone ELISA kit. Ag NPs (at 20 µg/ml) significantly (p < 0.001) 
decreased LH-stimulated testosterone production as compared to the control.  Our study was 
not able to determine the mechanism of the anti-androgenic action.  Additional studies are 
merited to ascertain the exact mechanisms involved. 
 
3.2 Introduction 
 
Ag NPs are said to be the most widely commercialised nanomaterial and it has found a wide 
range of applications in many different fields (Braydich-Stolle et al., 2010).  Due to their 
antimicrobial activity they have been incorporated into many consumer products to serve as 
antibiotic agents, including appliances such as washing machines and refrigerators, textiles, 
wound healing and medical products such as surgical instruments, contraceptive devices, 
bone prostheses as well as dental alloys (Stensberg et al., 2011; Tian et al., 2007; Kruszewski 
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et al., 2011).  The proliferation of applications of Ag NPs persists despite the lack of 
knowledge on the effects they have on the human body. 
After exposure (oral, intravenous, dermal and inhalation) Ag NPs showed a size-independent 
distribution and accumulation in multiple organs, including spleen, liver, heart, brain, 
kidneys, lymph nodes, skin and testes (Kim et al., 2010; Lankveld et al., 2010; Sung et al., 
2009).  Toxicological studies based on other metal nanoparticles, such as gold nanoparticles 
(Au NPs) and titanium-oxide nanoparticles (TiO2-NP’s) suggest that they decrease Leydig 
cell viability and steroid hormone production and that they decrease epididymal sperm 
motility and induce histopathological changes in mice testes, respectively (Komatsu et al., 
2008; Takeda et al., 2009).  The adverse effects of Ag NPs on the reproductive system are 
similar to those induced by other metal nanoparticles.  Braydich-Stolle et al. (2010) showed 
that Ag NPs cause a decrease in the proliferation of spermatogonial stem cells.   Gromadzka-
Ostrowska et al. (2012) found that Ag NPs decreased the sperm count, increased abnormal 
spermatozoa and caused germ cell DNA damage in sperm cells and testis morphometry.  
Testosterone is a major androgenic hormone that is responsible for, inter alia, the 
development of male reproductive structures, male secondary characteristics, as well as 
maintaining proper sperm cell production (Seeley et al., 2008; Martini et al., 2012).  To our 
knowledge, there is no scientific data available on the effect of Ag NPs on testosterone 
production.  
The US Environmental Protection Agency has recommended the sectioned or minced testes 
assay as the preferred method for screening the effect of substances on steroid hormone 
production and secretion (EPA, 2005).  This assay has several advantages, including low 
cost, rapidity, simplicity, and the requirement of standard laboratory equipment and 
elementary laboratory training (EPA, 2005).  Studies done by Ebrahim & Pool (2010) 
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showed that this assay can be used to monitor the effects of compounds on testosterone 
production.  
The aim of this study is to utilise a minced testes assay to ascertain the effect of Ag NPs on 
steroidogenesis.  
 
3.3 Materials and Methods 
 
3.3.1 Reagents and chemicals  
 
All chemicals, reagents, and solvents were purchased from Sigma (Germany), unless 
otherwise stated in the text.  All reagents were of analytical grade. 
3.3.2 Characterisation of silver nanoparticles (Ag NPs) 
 
The Ag NPs in powder form (CAT no. 7440-22-4) was purchased from Sigma-Aldrich, South 
Africa.  The manufacturer’s specifications stated that the Ag NPs were <100 nm spherical 
nanoparticles with a specific surface area of 5.0 m
2
/g, density of 10.49 g/cm
3
 and a purity of 
99.5 % based on trace metal analysis.  Characterisation studies were undertaken to confirm 
the manufacturer’s specifications. 
3.3.2.1 Scanning Electron Microscopy (SEM) analysis of Ag NPs 
 
SEM analysis was done using an EVO® MA15 Scanning Electron Microscope (SEM).  A 
drop of Ag NPs suspension was pipetted onto the carbon surface of an SEM stub.  Primary 
electron and/or secondary electron images were taken to identify the sample.  
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3.3.2.2 Energy-Dispersive X-ray (EDX) analysis of Ag NPs 
 
The SEM had EDX spectrometry capabilities and this was used simultaneously during the 
SEM analysis in order to confirm the presence of Ag.  The Ag NPs composition was 
quantified by EDX analysis using an Oxford Instruments® X-Max 20 mm
2
 detector and 
Oxford INCA software (refer to Figure 3 under section 3.4.1.2). 
3.3.2.3 Transmission Electron Microscopy (TEM) analysis of Ag NPs 
 
Ag NPs’ size and morphology were determined via TEM analysis using a JEOL 1200-EX II 
electron microscope at an accelerating voltage of 120 kV.  A MegaView Camera employing 
Gatan Microscopic software with a resolution of 1376x1032, and 2 second exposure time was 
used to obtain images of the Ag NPs.  A suspension of Ag NPs was dissolved in ethanol, and 
thereafter deposited onto copper grids and air-dried.  Particle size distribution based on the 
TEM images was generated using ImageJ software.  
3.3.2.4 Brunauer, Emmet and Teller (BET) analysis of Ag NPs 
 
ASAP 2010 (Accelerated Surface Area and Porosimetry System; Micromeritics Instrument 
Corporation) was employed to determine the Ag NPs surface area.  The Ag NP sample was 
degassed overnight at 100 °C before being analysed.  
3.3.2.5 Powder X-Ray Diffraction (PXRD) analysis of Ag NPs 
 
The crystalline nature of the Ag NPs was determined using PXRD (Panalytical X’pert Pro).  
The PXRD pattern was collected between angles of 2Θ from 3° to 90°. 
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3.3.2.6 Ultraviolet- visible (UV-vis) Spectroscopy of Ag NPs 
 
A Helios Omega UV-VIS Spectrophotometer (Thermo Scientific) scanning from 400 to 1100 
nm was used to measure light intensity as a function of wavelength.  The Ag NP sample was 
suspended in dimethlyformamide (DMF) to prepare solutions for measurements. 
3.3.3 Animals  
 
Three month old, pathogen-free, male Balb/C mice were used for this study.  Mice were 
purchased from the University of Cape Town Animal Unit (Cape Town, South Africa).  The 
mice were housed in a well-ventilated animal house with a 12 hour light/dark cycle and fed 
standard mouse feed (Medical Research Council, Cape Town, South Africa) with free access 
to normal drinking water. 
3.3.4 Cell culture 
 
Mice were sacrificed by cervical dislocation.  The testes were subsequently removed 
(aseptically), minced and then suspended in 10 ml serum-free medium which consisted of 1 
% glutamax (Invitrogen), 1 % Penicillin/Streptomycin/Fungizone mix (Sigma), and 0.5 % 
Gentamicin (Sigma) in RPMI-1640 medium (Sigma).  After allowing debris to settle, the 
supernatant containing cells were transferred to a new sterile tube.  The cells were thereafter 
incubated at 37 ˚C with 5 % CO2 for 1 hour.  Following the incubation period, the cells were 
centrifuged at 40 000 x g for 10 minutes.  The supernatant was then discarded and the cell 
pellet was resuspended in 10 ml serum-free medium and incubated at 37 ˚C with 5 % CO2 for 
30 minutes.  The cells were centrifuged at 40 000 x g for 10 minutes and the supernatant 
obtained was again discarded.  The cell pellet was then resuspended in 10 ml serum-free 
medium to an approximate concentration of 5 x 10
6
 cells/ml for use in cell culture assays. 
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3.3.5 Preparation of Ag NPs 
 
A 5 ml stock solution of 2mg/ml Ag NPs (Sigma) was prepared and then diluted with the 
serum-free medium described in the previous paragraph,  to make up a 40 µg/ml sample to be 
used on the cell cultures.  Due to the dilution factor associated with the protocol of the 
experiment, the final concentration of Ag NPs used was equal to 20 µg/ml. 
3.3.6 Determination of the effect of Ag NPs on the production of 
testosterone 
 
To determine the effect of the Ag NPs on the ability of the mouse testicular cells to produce 
testosterone, 100 µl of the serum-free medium was added to 6 columns of a 96 well plate 
(refer to Figure 1) in order to have replicates of 3 (3 columns LH minus & 3 columns LH 
plus).  Stock Ag NP solution (100 µl at 40 µg/ml) was added to each well of the first row and 
then serial dilutions were performed to decrease the concentrations of Ag NPs in each 
subsequent row (refer to Figure 1).  Prepared cell culture (50 µl per well) was then added to 
this mixture and the plate was incubated at 37 ˚C with 5 % CO2 for 4 hours.  An LH 
preparation, consisting of 0.04 %  sheep pituitary LH (Sigma) in medium, consisting of 1 % 
glutamax (Invitrogen) and RPMI-1640 medium (Sigma), was prepared.  This LH medium (50 
µl per well) was added to the columns labelled LH Plus (columns 5-7).  The medium (50 µl 
per well), consisting of 1 % glutamax (Invitrogen) and RPMI-1640 medium (Sigma) only, 
was added to the columns labelled LH Minus (columns 2-4).  The plate was then allowed to 
incubate overnight at 37 ˚C with 5 % CO2.  
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3.3.7 Testosterone production analysis using a testosterone ELISA 
 
Following the overnight incubation, the plate was lightly shaken and the cells were allowed 
to settle.  The top layer (20 µl) of each well was then transferred to a storage plate.  A 4 x 
diluted wash buffer (180 µl) provided by the testosterone enzyme-linked immunosorbant 
(ELISA) kit (DRG Instruments, GmbH, Germany) was then added to these samples.  These 
mixtures (25 µl per well) was then transferred to the ELISA plate and the rest of the assay 
was performed as per manufacturer’s instructions (refer to Figure 2).  All the required 
reagents were provided in the kit.  The microtitre wells of the ELISA plate was coated with a 
monoclonal (mouse) antibody directed towards a unique antigenic site on the testosterone 
molecule.  Standards or samples were added to the ELISA plate (25 µl/well).  Subsequently, 
200 µl/well of testosterone peroxidase conjugate was added for binding to the coated 
antibody.  The contents in the wells were then incubated and mixed for 60 minutes.  
Afterwards, the wells were washed three times with 400 µl/well wash solution consisting of 
5-bromo-5-nitro-1, 3-dioxane (BND) and 2-methyl-2H-isothiazol-3-one (MIT) and tapped 
dry.  Then, 200 µl/well of the substrate solution, tetramethylbenzidine (TMB), was added.  
After mixing, the plate was allowed to incubate for 15 minutes at room temperature.  The 
enzymatic reaction was stopped by adding 100 µl/well of the stop solution consisting of 0.5 
M sulphuric acid (H2SO4).  The optical density (OD) was read at 450 nm with a microtitre 
plate reader (Thermo Electron Corporation, Original Multiskan Ex).  The 0 ng/ml standard 
results in maximum binding of the testosterone horseradish conjugate.  All data was 
expressed as a percentage of 0 ng/ml standard.  A standard curve was drawn using the results 
obtained for the testosterone standards.  The testosterone concentrations of the samples tested 
were read using this curve.
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Figure 1: Plate layout for the determination of the effect of Ag NPs on testosterone production by testis cell cultures 
No LH added LH added 
Ag NP 
(µg/ml) 
1 2 3 4 5 6 7 8 9 10 11 12 
A = 20             
B = 10             
C = 5             
D = 2.5             
E=1.25             
F=0.625             
G=0             
H= 
Medium 
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Culture supernatants  
No LH added LH added 
 Standards of 
testosterone (ng/ml) 
2 3 4 5 6 7 
A 16       
B 6       
C 2       
D 1       
E 0.5       
F 0.2       
G 0       
H        
Figure 2: Plate layout for testosterone ELISA 
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3.3.8 Statistical analysis  
 
SigmaStat software (Systat Software Inc., USA) was used for statistical analysis.  The 
experiments were performed nine (9) times in triplicate and data was statistically analysed via 
one-way ANOVA (P < 0.001) and regression analysis.  
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3.4 Results 
3.4.1 Characterisation of silver nanoparticles (Ag NPs) 
 
3.4.1.1 Scanning Electron Microscopy (SEM) analysis of Ag NPs 
 
SEM analysis showed that the Ag NPs formed small, loosely packed aggregates of no more 
than 100 nm in size (refer to Figure 3). 
3.4.1.2 Energy-Dispersive X-ray (EDX) analysis of Ag NPs 
 
EDX analysis showed elemental Ag composition of Ag NPs (refer to Figure 3). 
 
 
 
 
 
 
 
 
Figure 3: SEM image of Ag NPs showing spherical particles in the order of 100 nm (top) 
and its corresponding EDX spectrum showing elemental Ag composition (bottom) 
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3.4.1.3 Transmission Electron Microscopy (TEM) analysis of Ag NPs 
 
3.4.1.3.1 TEM analysis of dry Ag NPs powder 
 
Like SEM analysis, TEM analysis showed that the Ag NPs formed small, loosely packed 
aggregates of no more than 100 nm in size.  Figure 4 can be consulted for the primary and 
aggregate size of Ag NPs in the dry state.  The spherical nature of the Ag NPs was verified by 
TEM images.  Particle size distribution revealed that the sample was mostly made up of 
smaller particles of the 10 nm range, with the second largest constituent of particles being 
located in the 20 nm range and then the rest of the sample being made up of larger particles in 
the 50-100 nm range. 
3.4.1.3.2 TEM analysis of Ag NPs suspended in aqueous medium 
 
Morphology and particle size distribution of Ag NPs were determined for Ag NP suspension 
under ambient conditions (average temperature = 14.6 °C).  TEM analysis revealed the 
continuous aggregation of Ag NPs in suspension (refer to Figure 5).  The particle size 
distribution also revealed that Ag NPs increased rapidly in size when suspended in an 
aqueous medium.  Most of the Ag NPs were found in the 20-40 nm range in the suspended 
sample compared to the dry sample, which had most of the particles located in the 10-20 nm 
range (refer to Figure 5 & Figure 4, respectfully).  The suspended samples also contained a 
smaller quantity of Ag NPs outside of the nm range (0,2-1 µm), effectively, no longer  
making them nanoparticles (refer to Figure 5). 
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Figure 4: TEM image of Ag NPs taken at 30 000 magnitude (left). Particle size distribution 
of Ag NPs confirming that NPs were < 100 nm (right) 
 
 
 
 
 
 
Figure 5: TEM image of Ag NPs in aqueous suspension taken at 20 000 magnification and 
associated histogram of particle distribution 
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3.4.1.4 Brunauer, Emmet and Teller (BET) analysis of Ag NPs 
 
BET analysis revealed the surface area of the Ag NPs to be 7.5329 m
2
/g ± 0.0028 (refer to 
Figure 6).  
 
 
 
 
 
Figure 6: BET result 
 
3.4.1.5 Powder X-Ray Diffraction (PXRD) analysis of Ag NPs 
 
The PXRD pattern recorded for Ag NPs is shown in Figure 7, and demonstrated the 
crystalline nature of the Ag NPs. 
 
 
 
 
 
 
Figure 7: PXRD pattern of Ag NPs 
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3.4.1.6 Ultraviolet- visible (UV-vis) Spectroscopy of Ag NPs 
 
The UV–vis absorption spectrum of the Ag NPs obtained is shown in Figure 8, with 
absorbance spectra at λ max = 422 nm. 
 
 
 
 
 
 
Figure 8: UV-vis spectrum of Ag NPs dissolved in deionized water 
 
Table 5: Summary of characteristics of Ag NPs used in this study 
Test Manufacturer’s 
specifications 
In-house characteristic 
SEM <100 nm Loosely packed aggregates, <100 nm 
EDX 99.5 % pure 99.5 % pure 
TEM of  
dry powder 
No data Mainly < 20 nm (87.5 %),  
30-50 nm (10.7 %),  
>50-100 nm (1.8 %) 
TEM of  
aqueous med. 
No data  Mainly 20 - 40 nm (66.7 %),  
>40-200 nm (11.1 %),  
>200-1000 nm (22.2 %) 
BET 5 m
2
/g
 
7.5329 m
2
/g 
PXRD No data Crystalline  
UV-vis No data λ max = 422 nm. 
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3.4.2 Effects of Ag NPs on testosterone production 
 
Ag NPs significantly decreased (P < 0.001) LH-induced testosterone secretion at a 
concentration of 20 µg/ml as compared to the control (Figure 9).  At 20 µg/ml, Ag NPs 
caused > 50% reduction in testosterone secretion in LH-stimulated cells as compared to the 
control.  Cells incubated in the absence of LH secreted low levels of testosterone and showed 
no significant effect as compared to the control.  
 
Figure 9: Effect of silver nanoparticles on testosterone secretion (with/without LH-
treatment).  Cells were treated for 4 hours and supernatants were screened thereafter for 
testosterone.  (* indicates P < 0.001 relative to the rest of the nanoparticle-treated samples; 
error bars indicate Standard Error of the Mean n=9) 
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3.5 Discussion  
 
Characterisation of the Ag NPs revealed that it indeed was spherical nanoparticles, which 
when in suspension is mostly found to be in the 20-40 nm range (refer to Figure 5).  Analysis 
via EDX confirmed that the nanoparticles contained silver (refer to Figure 3).  
Testosterone synthesis occurs under LH stimulation of Leydig cells during steroidogenesis.   
LH initiates this complex, multienzyme process when it binds to the membrane-bound LH 
receptors, stimulating the production of cAMP (Hales, 2002).  Steroidogenic Acute 
Regulatory Protein (StAR) transfers cholesterol from the outer mitochondrial membrane into 
the inner mitochondrial membrane, a process which is cAMP-dependent (Stocco et al., 2000).  
This is the rate limiting step in steroidogenesis (Crivello & Jefcoate, 1980; Mori & Marsh, 
1982; Privalle et al., 1983).  Cholesterol is converted to pregnenolone via cytochrome P450 
side chain cleavage enzyme (P450scc) (Stocco et al., 2000; Payne and Hales, 2004).  After 
the dispersion of pregnenolone to the smooth endoplasmic reticulum, it is converted to 
progesterone by 3β-hydroxysteroid dehydrogenase-Δ4-Δ5 isomerase (3β-HSD) (Hales, 2002).  
Cytochrome P450 17α- hydroxylase/C17-20 lyase (P450c17) converts pregnenolone to 17α-
hydroxypregnenolone and then to dehydroepiandrosterone (Chung et al., 1987). 17ß-
hydroxysteroid dehydrogenase (17ß- HSD) then converts androstenedione to testosterone 
(Hales, 2002). 
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Figure 10: Summary of the steroidogenic pathway within the Leydig cells upon stimulus by 
LH (Bulun et al., 2005; Flück et al., 2003). 
Our results indicated that the statistical significant (p<0.001) decrease in testosterone 
production only occurred at the highest concentration (20 µg/ml) of Ag NPs.  The results 
obtained from the XTT and WST-1 assays were inconclusive (results not shown).  The Ag 
NPs reacted with the XTT and WST-1 substrates and resulted in very high background 
readings.  Our results do not suggest a mechanism of action, but there are several ways in 
which silver nanoparticles could be affecting the production of testosterone.  Ag NP-induced 
decrease in testosterone production could be due to an inhibition of the steroidogenesis 
pathway, either by inhibiting StAR expression and/or action (cholesterol transport), cAMP, 
protein kinase A, or the activity of steroidogenic enzymes.  Steroidogenesis is a complex, 
multienzyme process that can be disrupted at various points by various mechanisms.  It only 
takes one of these points to be disrupted for testosterone production to be significantly 
decreased.  
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Steroidogenesis has been shown to be inhibited by inflammatory mediators, viz. cytokines 
and reactive oxygen species (ROS) (Hales, 2002) (refer to Figure 11).  Hales et al. (1999) 
states that under normal physiological conditions cytokines and other inflammatory mediators 
play a positive role in the development and differentiation of Leydig cells.  However, 
overexpression of pro-inflammatory cytokines, such as interleukin-1 (IL-1) and tumor 
necrosis factor (TNF–α), produced by activated macrophages has been shown to significantly 
inhibit Leydig cells and seem to act as transcriptional repressors of steroidogenic enzyme 
gene expression (Hong et al., 2004; Mauduit et al., 1998; Lin et al., 1991).  ROS has even 
been associated with male infertility (Aitken & Krausz, 2001).  ROS is continuously 
produced within the cell as a common by-product of metabolic processes, such as 
mitochondrial and microsomal electron transport reactions (Hales, 2002).  Cells are usually 
protected from the harmful effects of these ROS by the cellular antioxidant systems, which 
includes, inter alia, superoxide dismutase (SOD), catalase and glutathione peroxidases 
(Finkel, 2003).  Failure of the cellular oxidative systems to counteract the production of ROS, 
leads to an imbalance, known as oxidative stress (Finkel & Hollbrook, 2000).  Oxidative 
stress is what has been cited to be detrimental to reproductive function (Ahotupa & 
Huhtaniemi, 1992).  
Diemer et al. (2003) found that ROS causes inhibition of StAR protein expression and 
therefore prevented the transport of cholesterol from the outer mitochondrial membrane to the 
inner mitochondrial membrane.  As stated earlier this is the rate-limiting step in 
steroidogenesis (Crivello & Jefcoate, 1980; Mori & Marsh, 1982; Privalle et al., 1983).  MA-
10 tumor Leydig cells were subjected to varying concentrations of ROS (hydrogen peroxide 
& xanthine oxidase) (Diemer et al., 2003).  It was found that ROS inhibited StAR protein 
expression and cAMP-mediated progesterone production in a dose-dependent manner 
(Diemer et al., 2003).  ROS was found not to induce cell death and it had no effect on P450 
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side-chain cleavage enzyme protein levels (Diemer et al., 2003).  The study found that ROS 
caused mitochondrial depolarisation and degeneracy of the mitochondrial membrane 
potential, which inhibited StAR protein and thus Steroidogenesis (Diemer et al., 2003).  
Murugesan et al. (2007) also found that ROS inhibited StAR protein expression. 
AshaRani et al. (2009) assessed the toxicity of starch-coated Ag NPs using two human cell 
lines.  Ag NPs induced mitochondrial damage, oxidative stress (radical oxygen species), and 
DNA damage in a dose dependent manner (AshaRani et al., 2009).  The authors proposed the 
following mechanism of toxicity for Ag NPs: disruption of the mitochondrial respiratory 
chain, leading to production of radical oxygen species and interruption of ATP synthesis, 
which in turn cause DNA damage (AshaRani et al., 2009).  Several other studies has also 
shown that Ag NPs induce reactive oxygen species (ROS) formation upon entry into the cell 
(Piao et al., 2011; Kim et al., 2009; Carlson et al., 2008).   
Carlson et al. (2008) investigated the size-dependent cellular interactions of Ag NPs on 
alveolar macrophages.  Ag NPs of 15 nm, 30 nm, and 55 nm were used to determine if ROS 
generation was size dependent.  It was found that the 15 nm Ag NPs were the most toxic of 
the three Ag NPs tested (Carlson et al., 2008).  Carlson et al. (2008) suggested that the 15 nm 
Ag NPs induced cytotoxicity of the cells via oxidative stress, as it caused a 10-fold increase 
in ROS levels in cells exposed to 50 µg/ml.  The 15 nm Ag NPs also decreased cell viability, 
decreased mitochondrial membrane potential and completely depleted glutathione levels 
(GSH) (Carlson et al., 2008).  It is interesting to note that the majority of the Ag NPs in our 
sample are located in the 10-20 nm range, which makes it possible that there could be a 
number of 15 nm sized Ag NPs within our sample.  Carlson et al. (2008) also found that the 
Ag NPs activated the macrophages to release pro-inflammatory cytokines, such as tumor 
necrosis factor (TNF–α) and macrophage inhibitory protein (MIP–2).    
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Figure 11: Inflammatory mediator sites of inhibition of Leydig cells (Hales, 2002).  Refer to 
Hales (2002) for a detailed review on the inflammatory mediators that inhibit Leydig cell 
steroidogenesis. 
Ag NPs in our study have been found to decrease testosterone.  Low testosterone has not only 
been associated with negative effects on reproductive health, but has also been implemented 
in several diseases, such as Alzheimer’s disease, anaemia, depressive illness, and type 2 
diabetes  (Ding et al., 2006; Ferrucci et al., 2006; Shores et al., 2004; Moffat et al., 2002).  
From the data obtained in this study, namely, inhibition of testosterone synthesis by Ag NPs, 
it can be concluded that Ag NPs may have several adverse effects on exposed males. 
Apart from the detrimental effects on steroidogenesis, oxidative stress has also been linked to 
oxidative damage of spermatozoa, resulting in loss of sperm function (Aitken & Krausz, 
2001).  The high concentration of polyunsaturated fatty acids within the plasma membrane of 
human spermatozoa is what makes them so susceptible to oxidative stress (Jones et al., 1979).  
There is irrefutable evidence implicating oxidative stress with DNA damage in spermatozoa 
and male germ line, and this may be connected with pathology in the offspring (for a review 
see: Aitken & Krausz , 2001).  
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As with regards to the rest of the bodily functions and processes, steroidogenesis is also 
highly regulated and dependent on homeostasis being present.  The right degree of expression 
of both cytokines and ROS seems to help regulate Leydig cell steroidogenesis.  However, 
under pathological conditions resulting in the overexpression of both cytokines and ROS, 
there appears to be a disturbance of this homeostasis leading to an inhibition of 
steroidogenesis.  Ag NPs have been shown to induce the overexpression of both cytokines 
(pro-inflammatory mediators) and ROS, leading to oxidative stress and as evidenced by this 
study, a decrease in Leydig cell testosterone production. 
3.6 Conclusion 
 
Male reproductive ability is reliant on the ability of the testes to manufacture sufficient levels 
of androgens (testosterone) and high volumes of viable sperm.  The results from this study 
demonstrated that Ag NPs conspires to mitigate this capacity, as evidenced by the decrease in 
testosterone production at 20 µg/ml of Ag NPs.  Our study was unable to impart a mechanism 
of action.  However, literature has strongly suggested that oxidative stress, through ROS and 
cytokine overexpression, could be the reason for the negative effects on steroidogenesis.  It 
would be interesting to see this hypothesis being tested in future studies.  
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Chapter 4: Further recommendations 
 
This study is a necessary starting point for assessing the effects of Ag NPs on 
steroidogenesis.  Therefore, it is only natural that further research questions would emerge 
from this study, if the results merit additional investigation.  As the results showed clear 
evidence of Ag NPs interfering with steroidogenesis (decreasing testosterone synthesis), it is 
self-evident that further research is needed.  There are two key issues that have to be 
investigated further, including the real mechanism by which Ag NPs inhibit testosterone 
production and the effect of serum proteins on this Ag NP-driven inhibition.  However, for 
the successful investigation of these two issues, it seems critical that toxicological kits that 
are designed to be used in the investigation of nanoparticle toxicity needs to be developed.  
 
4.1 The mechanism of action 
 
It would be of great significance to determine the nature by which these Ag NPs exert their 
effects.  Our study has deduced that the mechanism of Ag NPs toxicity could be driven by 
oxidative stress, causing ROS formation and cytokine expression.  These products have been 
shown to affect several enzymes in the steroidogenesis pathway including StAR protein 
(Diemer et al., 2003).  Since this is all speculation, empirical evidence still needs to be 
provided. 
The US Environmental Protection Agency has recommended the sectioned or minced testes 
assay as the preferred method for screening the effect of substances on steroid hormone 
production and secretion (EPA, 2005).  This assay has several advantages of which one is the 
ability to assess multiple endpoints.  Multiple endpoints, such as testing progesterone, 
testosterone and estradiol could give better inside into the mechanism of action of Ag NPs 
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than just measuring testosterone alone.  This might be easier to visualise with the aid of a 
diagram.  
 
 
 
 
 
 
 
 
 
Figure 12: Steroidogenic pathway with multiple endpoints (Bulun et al., 2005) 
Assessing the effects of Ag NPs on progesterone, testosterone, and estradiol would impart 
information on the particular step in the steroidogenesis pathway the Ag NPs act on.  If 
progesterone levels are normal, but the testosterone levels are decreased, then perhaps the Ag 
NPs inhibit the effect of cytochrome P450 17α- hydroxylase/C17-20 lyase (P450c17) or 17ß-
hydroxysteroid dehydrogenase (17ß- HSD).  However, if it were detected that the estradiol 
levels are increased, then it would be assumed that the Ag NPs increases the activity of 
aromatase cytochrome P450 (P450arom).  Therefore, the method of assessing multiple 
endpoints would give far greater insight into the mechanism of action or at least the sight of 
action, then just assessing one endpoint would. 
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4.2 Effect of serum proteins on nanomaterial toxicity  
 
For the purposes of medical applications the nanomaterials are introduced into the host 
organism via parenteral administration.  The body reacts against the NPs as foreign objects. 
There are many factors that dictate the kind of response the body mounts.  The nanomaterials 
are immediately covered by proteins when they are introduced to a biological matrix, 
resulting in what is termed a protein “corona” (Cedervall et al., 2007; Lynch & Dawson, 
2008).  Aggarwal et al. (2009), states that protein coronas are complex and variable.  
Opsonins, a component of the nanoparticle corona, are believed to increase the uptake of the 
coated nanoparticle by the cells of the reticulo-endothelial system (RES) (Patel, 1992; Chonn 
et al., 1992).  This effect is due to the “molecular signature” created by the opsonins being 
present on the nanoparticle surface which plays a major role in recognition by the immune 
cells and internalisation route (Kiwada et al., 1987; Tyrrell et al., 1977).  The route by which 
the nanoparticle is internalised has an effect on the rate of clearance of the nanoparticle and 
its contents from the bloodstream, its volume of distribution, organ deposition and rate and 
route of clearance from the body (Göppert & Müller, 2005a).  For larger particles protein 
binding is already established as one of the most important factors influencing biodistribution 
(Dutta et al., 2007; Gessner et al., 2002; Göppert & Müller, 2005b) 
Surface area seems to be one of the major determinants of the biological response to 
nanoparticles (Brown et al., 2001; Tran et al., 2000).  As already mentioned before, 
nanoparticles have a larger surface-to-volume ratio than larger particles, which means more 
proteins will bind to the smaller nanoparticles (in relation to its mass) than to the larger 
particles (Aggarwal et al., 2009).  Musteata et al. (2006) states that not only is protein binding 
of paramount importance to understanding the pharmacokinetics and pharmacodynamics of 
drugs in the body but it is also used to develop models to determine drug efficacy and 
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toxicity.  As mentioned earlier particle properties such as shape, size, solubility, surface 
modifications (including targeting) and route of administration all influence the way 
nanoparticles are distributed throughout the body.  Aggarwal et al. (2009) states that the 
missing link is in understanding the effect of these factors on the binding of serum proteins to 
the nanoparticles and how this in turn affects biodistribution, biocompatibility and therapeutic 
efficacy of nanoparticles.  Although the mechanism of serum protein binding is not well 
known, it is known that the amount and type of proteins attached to the surface of the 
nanoparticle has an effect on the biodistribution of the nanoparticle (Aggarwal et al., 2009). 
Nanoparticles are said to interact with approximately 50 proteins contained in the plasma of 
human blood (Aggarwal et al., 2009), as evidenced by numerous studies (Dobrovolskaia et 
al., 2009; Göppert & Müller, 2005c; Kim et al., 2007).  Aggarwal et al. (2009) lists numerous 
nanoparticles and the types of serum proteins that have affinity to them (Table 1 in Aggarwal 
et al. 2009).  Albumin, fibrinogen, IgG and IgM seem to be the most commonly found 
proteins on nanoparticles; appearing on the surfaces of several nanoparticles including 
liposomes, single- and double-walled carbon nanotubes, iron oxide nanoparticles, and 
Poly(D,l-lactic acid) nanoparticles, etc.  Different opsonins have specific effects on the fate of 
the nanoparticle it is bound to.  It is said that the binding of albumin to a nanoparticle 
increases its circulation time within the blood, while the binding of fibrinogen, IgG and 
complement are believed to promote phagocytosis and the subsequent elimination of the 
nanoparticles from the blood through the RES (Göppert & Müller, 2005c; Ogawara et al., 
2004; Camner et al., 2002).  Owens & Peppas (2006) and Roser et al. (1998) found that 
surface charge influences protein binding since neutral particles have a slower rate of 
opsonisation than their charged counterparts.  Hydrophobic nanoparticles have a faster rate of 
opsonisation than hydrophilic nanoparticles (Owens & Peppas, 2006).  Hydrophobicity is 
also said to impact on the degree of opsonisation as well as the type of proteins that bind to 
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the nanoparticles (Cedervall et al., 2007; Göppert & Müller, 2005a; Göppert & Müller, 
2005b).  Owens & Peppas (2006) found that several factors, including shape, size, 
morphology and surface curvature all influence the degree of opsonisation, but not the type of 
bound proteins. 
It would be remarkable to see what effect the serum proteins would have on the seeming anti-
androgenic effect of Ag NPs.  
4.3 Development of cytotoxicity assays that are specific for nanoparticles  
 
Kroll et al. (2009) made a review on some of the nanoparticles that interfere with different 
cytotoxic assays.  Single-walled carbon nanotubes (SWCNTs) were found to form crystals 
with the MTT assay (Wörle-Knirsch et al., 2006).  In another study, SWCNTs were found to 
increase WST-1 absorbance when the concentration of SWCNTs was increased (Casey et al., 
2007).  Our study encountered problems, when it was found that the WST-1 and XTT assays 
were not working when used with Ag NPs.  Both of these assays require absorbance 
assessment at around 500 nm.  Many nanoparticles absorb at this wavelength and could 
account for the problem we experienced (Kong et al., 2011). 
To combat the possibility of interference by the nanoparticles, it is suggested that at least two 
or more independent cytotoxicity assays be performed (Kong et al., 2011; Wörle-Knirsch et 
al., 2006). It would also be advantageous, if cytotoxicity assays that are specific for 
nanoparticles could be developed. 
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